Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Neuro-Ophthalmology

Building Your Care Team & Appointment Prep

At a Glance

AAION is an optic nerve emergency requiring coordinated care from an eye specialist, rheumatologist, and primary care clinician. Bring your steroid timeline, lab and biopsy reports, imaging, and medication list, and seek urgent help for new vision changes or severe chest, back, or abdominal pain.

Managing Arteritic Anterior Ischemic Optic Neuropathy (AAION) is a team effort. Because it involves both a sudden eye emergency and a long-term inflammatory disease (Giant Cell Arteritis or GCA), you will need several specialists working together to protect your vision and manage your overall health [1][2].

Your Core Medical Team

A common care arrangement typically includes three key players who communicate frequently [3][4].

  • Neuro-ophthalmologist (or Ophthalmologist): This is your eye specialist [3]. They focus on the health of your optic nerve. They will perform regular tests to monitor your visual fields, color vision, and eye pressure, and they are the first person you should contact if you notice any new changes in either eye [5][6].
  • Rheumatologist: This is your inflammation specialist [4]. They help guide the treatment of the underlying GCA. They will manage your long-term steroid taper, decide when to add steroid-sparing medications like tocilizumab, and monitor you for signs that the disease is affecting other large blood vessels in your body [7][8].
  • Primary Care Physician (PCP) or Geriatrician: Your “home base” doctor focuses on your total health [9]. High-dose steroids can cause side effects like high blood sugar, bone loss (osteoporosis), and high blood pressure [7][9]. Your PCP will coordinate screenings for these issues, manage your vaccinations, and help you navigate the psychological impact of the diagnosis [9][4].

Preparing for Your First Specialist Visits

When you see a specialist for the first time after a hospital stay or diagnosis, you are the most important source of information [10]. To ensure they have the full picture, you should bring the following “artifacts” to every first appointment:

  • The Steroid Timeline: This is the most critical record [1][6]. Write down the exact date and time of your first-ever dose of steroids, whether it was given via IV or as a pill, and any changes in the dosage since then [6][10]. This timing helps doctors interpret your test results and judge your risk for future vision loss [10][11].
  • Lab Results: Bring copies of your blood tests, specifically the exact values for your ESR, CRP, and platelet count [12]. It is helpful to have the results from before you started steroids, if possible [13][14].
  • Biopsy and Imaging Reports: Bring the full pathology report from your temporal artery biopsy (not just a summary) [15]. If you had an ultrasound, MRI, or PET-CT, ask for the images to be put on a disc for the specialist to view personally (though many systems now transfer these electronically) [16][17].
  • Medication and Comorbidity List: List all other health conditions (like diabetes or glaucoma) and every medication or supplement you take [18].

Seeking Specialized Care

Some hospitals offer “fast-track” clinics specifically designed to evaluate suspected GCA within 24 hours [2][19]. However, you should receive immediate emergency treatment locally rather than wait for a referral. Organizing your records and vetting your team early can give you peace of mind and ensure you receive the most proactive care available [2][20]. Note that sudden severe chest, back, or abdominal pain requires an immediate call to emergency services.

Common questions in this guide

Which doctors usually treat AAION linked to giant cell arteritis?
Care commonly includes a neuro-ophthalmologist or ophthalmologist, a rheumatologist, and a primary care doctor or geriatrician. The eye specialist monitors vision and optic nerve health, the rheumatologist manages giant cell arteritis treatment, and primary care helps coordinate overall health and steroid safety.
What should I bring to my first AAION or GCA appointment?
Bring a written timeline showing the exact date and time, route, and dose of your first steroid treatment, along with later dose changes. Also bring your ESR, CRP, and platelet results, the full temporal artery biopsy report, available imaging or discs, and a complete list of health conditions, medicines, and supplements.
Why do doctors need to know exactly when my steroids were started?
Steroids can affect how doctors interpret later tests and the overall clinical picture. Knowing when treatment began helps the team assess the risk of additional vision loss and understand what your results mean.
What if my temporal artery biopsy is negative but I still have symptoms?
A negative biopsy does not automatically settle whether giant cell arteritis is present. Ask your care team what additional clinical assessment, blood tests, imaging, or other steps they will use to confirm or manage the diagnosis.
What should I do if my vision changes after an AAION diagnosis?
Contact your eye specialist immediately about any new change in either eye and follow local emergency instructions. Do not wait for a fast-track clinic or referral before receiving urgent treatment.
How will my care team monitor GCA and steroid-related risks?
Your rheumatologist and primary care clinician can monitor for giant cell arteritis affecting larger blood vessels and for steroid-related problems such as high blood sugar, bone loss, and high blood pressure. Ask which tests or imaging and follow-up schedule are appropriate for you, and call emergency services for sudden severe chest, back, or abdominal pain.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many cases of vision-threatening GCA or AAION does your practice manage each year?
  2. 2.Do you have a 'fast-track' protocol that ensures I can be seen within 24 hours if my vision changes?
  3. 3.Which one of you will be the 'quarterback' coordinating my care between ophthalmology, rheumatology, and my primary doctor?
  4. 4.How do you and the rest of the team share notes and test results to ensure everyone is on the same page?
  5. 5.If my biopsy is negative but my symptoms continue, what is your specific 'Plan B' for confirming my diagnosis?
  6. 6.What is your protocol for monitoring me for large-vessel complications, such as an aortic aneurysm, in the long term?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Giant Cell Arteritis: Updates and Controversies.

    Yu E, Chang JR

    Frontiers in ophthalmology 2022; (2()):848861 doi:10.3389/fopht.2022.848861.

    PMID: 38983551
  2. 2

    [Recommendations for defining giant cell arteritis fast-track clinics].

    Schmidt WA, Czihal M, Gernert M, et al.

    Zeitschrift fur Rheumatologie 2024; (83(9)):762-765 doi:10.1007/s00393-024-01519-6.

    PMID: 38717506
  3. 3

    Giant Cell Arteritis.

    Ness T, Nölle B

    Klinische Monatsblatter fur Augenheilkunde 2024; (241(5)):644-652 doi:10.1055/a-2252-3371.

    PMID: 38593832
  4. 4

    Diagnosis, Treatment, and Follow-Up of Giant-Cell Arteritis: A Retrospective Multicenter Study.

    Kang MK, Hong Y, Kim YH, et al.

    Journal of clinical neurology (Seoul, Korea) 2024; (20(3)):306-314 doi:10.3988/jcn.2023.0169.

    PMID: 38627226
  5. 5

    Preserved Visual Acuity in Anterior Ischemic Optic Neuropathy Secondary to Giant Cell (temporal) Arteritis.

    Antonio-Santos AA, Murad-Kejbou SJ, Foroozan R, et al.

    Journal of vascular and interventional neurology 2016; (8(5)):17-21.

    PMID: 26958148
  6. 6

    Vision loss in giant cell arteritis: case-based review.

    Kokloni IN, Aligianni SI, Makri O, Daoussis D

    Rheumatology international 2022; (42(10)):1855-1862 doi:10.1007/s00296-022-05160-x.

    PMID: 35727336
  7. 7

    Prognosis and monitoring of giant cell arteritis and associated complications.

    Kermani TA, Warrington KJ

    Expert review of clinical immunology 2018; (14(5)):379-388 doi:10.1080/1744666X.2018.1467758.

    PMID: 29676201
  8. 8

    Trial of Tocilizumab in Giant-Cell Arteritis.

    Stone JH, Tuckwell K, Dimonaco S, et al.

    The New England journal of medicine 2017; (377(4)):317-328 doi:10.1056/NEJMoa1613849.

    PMID: 28745999
  9. 9

    Giant cell arteritis: Diagnostic approach based on a retrospective study on 21 cases.

    Tounsi H, Aouni J, Kharrat G, et al.

    Vascular diseases (Paris, France) 2025; (50(2)):75-79 doi:10.1016/j.vasdi.2025.02.003.

    PMID: 40757620
  10. 10

    Temporal artery biopsy for suspected giant cell arteritis: A mini review.

    Jiang Z, Ji H, Dong J

    Indian journal of ophthalmology 2023; (71(10)):3299-3304 doi:10.4103/IJO.IJO_3163_22.

    PMID: 37787225
  11. 11

    The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study.

    Luqmani R, Lee E, Singh S, et al.

    Health technology assessment (Winchester, England) 2016; (20(90)):1-238 doi:10.3310/hta20900.

    PMID: 27925577
  12. 12

    Population-Based Performance of Inflammatory Markers in Giant Cell Arteritis.

    Castillejo Becerra CM, Crowson CS, Langenfeld HE, et al.

    American journal of ophthalmology 2025; (275()):47-51 doi:10.1016/j.ajo.2025.03.022.

    PMID: 40139650
  13. 13

    New developments in giant cell arteritis.

    Frohman L, Wong AB, Matheos K, et al.

    Survey of ophthalmology 2016; (61(4)):400-21.

    PMID: 26774550
  14. 14

    Posterior ischemic optic neuropathy as the main manifestation of giant cell arteritis: a case-based literature review.

    Barankiewicz-Tyc N, Wąsik N, Majewski P, et al.

    Reumatologia 2026; (64(1)):65-71 doi:10.5114/reum/207774.

    PMID: 41909066
  15. 15

    Varicella zoster virus triggers the immunopathology of giant cell arteritis.

    Gilden D, Nagel MA

    Current opinion in rheumatology 2016; (28(4)):376-82 doi:10.1097/BOR.0000000000000292.

    PMID: 27224742
  16. 16

    Biopsy vs imaging for the diagnosis of giant cell arteritis. Viewpoint 2: in favour of biopsy.

    Espígol-Frigolé G, Prieto-González S, Marco-Hernández J, et al.

    Rheumatology (Oxford, England) 2025; (64(12 Suppl 2)):i74-i78 doi:10.1093/rheumatology/keae474.

    PMID: 40071431
  17. 17

    Orbital magnetic resonance imaging of giant cell arteritis with ocular manifestations: a systematic review and individual participant data meta-analysis.

    Guggenberger KV, Pavlou A, Cao Q, et al.

    European radiology 2023; (33(11)):7913-7922 doi:10.1007/s00330-023-09770-2.

    PMID: 37256352
  18. 18

    Vision Loss From Giant Cell Arteritis in Patients With Other Ocular Diagnoses.

    Nichani P, Biousse V, Newman NJ, Micieli JA

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2021; (41(2)):e254-e258 doi:10.1097/WNO.0000000000001064.

    PMID: 32868559
  19. 19

    Advances in diagnosing and treating giant cell arteritis: New hope for arteritic anterior ischemic optic neuropathy.

    von der Emde L, Petzinna SM, Herwig-Carl MC, et al.

    Survey of ophthalmology 2025; doi:10.1016/j.survophthal.2025.06.009.

    PMID: 40541842
  20. 20

    Halo Sign on Temporal Artery Ultrasound Aids in Prompt Diagnosis of Giant Cell Arteritis.

    Laszlofy L, Bardoczi A, Husvethova D, et al.

    Methodist DeBakey cardiovascular journal 2025; (21(1)):100-105 doi:10.14797/mdcvj.1635.

    PMID: 41112312

This page is for informational purposes only and does not constitute medical advice. AAION and suspected giant cell arteritis require urgent medical care; follow your eye, rheumatology, and primary care teams for decisions about your situation.

Get notified when new evidence is published on arteritic anterior ischemic optic neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.